Vikas Sinha - 01 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Reporting relationship: Director
Issuer ticker: VRNA
Reported as of: 01 Aug 2025
Net transaction value: -$56,886
SEC form: 4
Accepted by SEC: 05 Aug 2025, 20:17:32 UTC
Prior SEC filing: 22 May 2025
Next SEC filing: 08 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Fisher, Attorney-in-fact for Vikas Sinha

Key filing fact

Vikas Sinha filed Form 4 for Verona Pharma plc (VRNA) on 05 Aug 2025.

Key facts

This page summarizes Vikas Sinha's Form 4 filing for Verona Pharma plc (VRNA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2025, 20:17.

Change

Previous filing in this sequence was filed on 22 May 2025.
Current net transaction value: -$56,886.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001337845 Primary reporting owner

Sinha Vikas

Relationship: Director
Address: 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM
Signature: /s/ Andrew Fisher, Attorney-in-fact for Vikas Sinha
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRNA transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +24,000
Change %: +32%
Price: $0.000000
Shares after: 98,440
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1

VRNA transaction

Ordinary Shares

Sale

Transaction value: $56,886
Shares: -4,328
Change %: -4.4%
Price: $13.14
Shares after: 94,112
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1, F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -24,000
Change %: -25%
Price: $0.000000
Shares after: 72,000
Date: 01 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 24,000
Exercise price
Footnotes: F1, F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

Footnote F2

The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").

Footnote F3

The price reported represents the sale price of the ADSs divided by eight (8).

Footnote F4

Consists of 94,112 Ordinary Shares represented by 11,764 ADSs.

Footnote F5

Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.

Footnote F6

The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.

SEC remarks

Exhibit 24 - Power of Attorney.